Development of NanoBRET Cellular Target Engagement Assays in Primary Neurons for Activating Mutants of p21-Activated Kinase 1
ACS Chemical Neuroscience · 21.10.2026 · 17 (20) · 3441-3452
DOI: 10.1021/acschemneuro.6c00326 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Chemical Neuroscience, online erschienen am 06.10.2026. Verfasst von Jacob L Capener und 8 weiteren Autor:innen. Beteiligte Einrichtung: Structural Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina27599, Unite…. Hauptthemen laut MEDLINE: p21-Activated Kinases, Neurons. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Leonard M. Miller School of Medicine, University of Miami, NINDS NIH HHS, Pharmaceutical Research and Manufacturers of America Foundation.
Abstract (Originalsprache)
The p21-activated kinases (PAKs) are a group of serine-threonine kinases central to multiple signaling pathways that govern cell survival and proliferation. Aberrant activity of PAK1, the most well characterized member of the PAK family, drives progression of several malignancies and brain disorders, including Alzheimer’s disease and neurodevelopmental disorders. Despite growing interest in PAK1 as a drug target for these diseases, there is no assay to evaluate the intracellular target engagement of PAK1 inhibitors. To address this need, we developed first-in-class NanoBRET assays for wild-type PAK1 and a neurodevelopmental disorder-causing gain-of-function PAK1 mutant. Furthermore, we executed our novel PAK1 NanoBRET assay to evaluate target engagement of PAK1 inhibitors in primary hippocampal neurons. To the best of our knowledge, this is the first demonstration of a NanoBRET cellular target engagement assay in primary neurons, thereby increasing the relevance of our work by confirming PAK1 inhibitor binding to the aberrant form of the protein in cerebral cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Structural Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina27599, United States.
- Department of Biochemistry and Molecular Biology, University of Miami Miller School of Medicine, Miami, Florida33136, United States.
- The Miami Project to Cure Paralysis, University of Miami, Miami, Florida33136, United States.
- Department of Neurological Surgery, Peggy and Harold Katz Drug Discovery Center, Sylvester Cancer Comprehensive Center, and Frost Institute for Data Science and Computing, University of Miami, Miami, Florida33136, Unite…
ORCID-Profile: Jacob L Capener, Bassel Awada, Frances M Bashore, Hassan Al-Ali, Alison D Axtman
Förderung
- Leonard M. Miller School of Medicine, University of Miami
- NINDS NIH HHS
- Pharmaceutical Research and Manufacturers of America Foundation
- National Institute of Neurological Disorders and Stroke
Zitieren
APA
Capener, J. L., Badillo-Martinez, A., Awada, B., Davis-Gilbert, Z. W., Kramer, T. W., Blair, C. S., Bashore, F. M., Al-Ali, H., & Axtman, A. D. (2026). Development of NanoBRET Cellular Target Engagement Assays in Primary Neurons for Activating Mutants of p21-Activated Kinase 1. ACS Chemical Neuroscience, 17(20), 3441-3452. https://doi.org/10.1021/acschemneuro.6c00326
Vancouver
Capener JL, Badillo-Martinez A, Awada B, Davis-Gilbert ZW, Kramer TW, Blair CS, et al. Development of NanoBRET Cellular Target Engagement Assays in Primary Neurons for Activating Mutants of p21-Activated Kinase 1. ACS Chemical Neuroscience. 2026;17(20):3441-3452. doi:10.1021/acschemneuro.6c00326
BibTeX
@article{Capener2026,
author = {Capener, Jacob L and Badillo-Martinez, Abdiel and Awada, Bassel and Davis-Gilbert, Zachary W and Kramer, Thomas W and Blair, Cameron S and Bashore, Frances M and Al-Ali, Hassan and Axtman, Alison D},
title = {Development of NanoBRET Cellular Target Engagement Assays in Primary Neurons for Activating Mutants of p21-Activated Kinase 1},
journal = {ACS Chemical Neuroscience},
year = {2026},
volume = {17},
number = {20},
pages = {3441--3452},
doi = {10.1021/acschemneuro.6c00326}
}
EUVIMED